MoneyWorks4Me

Dr. Reddy's Lab gets EIR for API manufacturing at Hyderabad

07 Oct 2019 Evaluate

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for its API manufacturing plant 2 at Bollaram in the state of Hyderabad, indicating closure of the audit and the inspection classification of this facility is determined as Voluntary Action Initiated (VAI).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..